Company / Net Debt per Share
Cogent Biosciences, Inc. Net Debt per Share History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.69
FY2025
5-year range
-$0.69 / -$0.69
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#60 of 85
Health Care
What the data says
At $-0.69, Cogent Biosciences, Inc.'s net debt per share ranks #26 of 85 in the Health Care sector.
Based on SEC 10-K filings.
-0.69 in FY2025.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#26 of 85 in Health CareTop 29% of 85This company -$0.69 Sector average $1.18
▼
-158.8% below sector average
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.69 | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026